Cardio Diagnostics Expands with Landmark PrecisionCHD Partnership in India
Market Chameleon (Wed, 7-Jan 2:31 AM ET)
Business Wire (Wed, 7-Jan 6:25 AM ET)
Business Wire (Tue, 6-Jan 8:35 AM ET)
Business Wire (Wed, 3-Dec 8:35 AM ET)
Business Wire (Wed, 5-Nov 8:35 AM ET)
Business Wire (Tue, 28-Oct 8:35 AM ET)
Business Wire (Tue, 21-Oct 8:35 AM ET)
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Cardio Diagnostics Hldgs trades on the NASDAQ stock market under the symbol CDIO.
As of January 8, 2026, CDIO stock price declined to $2.44 with 170,805 million shares trading.
CDIO has a beta of 2.16, meaning it tends to be more sensitive to market movements. CDIO has a correlation of 0.08 to the broad based SPY ETF.
CDIO has a market cap of $4.46 million. This is considered a Sub-Micro Cap stock.
Last quarter Cardio Diagnostics Hldgs reported $2,855 in Revenue and -$.98 earnings per share. This fell short of revenue expectation by $-147,145 and exceeded earnings estimates by $.82.
In the last 3 years, CDIO traded as high as $255.00 and as low as $2.33.
The top ETF exchange traded funds that CDIO belongs to (by Net Assets): VXF.
CDIO has underperformed the market in the last year with a price return of -90.6% while the SPY ETF gained +18.4%. CDIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -44.2% and -28.7%, respectively, while the SPY returned +3.4% and -0.1%, respectively.
CDIO support price is $2.54 and resistance is $3.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDIO shares will trade within this expected range on the day.